✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals

Epigral Ltd.

EPIGRAL

Market Cap
₹5,333 Cr.
P/E
16.06

Epigral Ltd.

  • Epigral
  • DCM Shriram
  • Guj. Alkalies & Chem

FAQs on Epigral Ltd. Shareprice

Epigral has given better returns compared to its competitors.
Epigral has grown at ~0.92% over the last 4yrs while peers have grown at a median rate of -2.0%

Epigral is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Epigral is 16.9, while 3 year average PE is 21.2.
Also latest EV/EBITDA of Epigral is 10.88 while 3yr average is 10.84.

View FAQ's On Business

Growth Table

  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem

Balance Sheet

  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem

Cash Flow

  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem

Quarterly Results

  • Epigral Ltd.
  • DCM Shriram
  • Guj. Alkalies & Chem

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Epigral Ltd. Financials

Balance sheet of Epigral is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Epigral is increasing.
Latest net debt of Epigral is ₹558 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹540 Crs.

The profit is oscillating.
The profit of Epigral is ₹333 Crs for TTM, ₹358 Crs for Mar 2025 and ₹196 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Epigral latest dividend payout ratio is 7.24% and 3yr average dividend payout ratio is 7.91%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech